We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DNL:ASXDyno Nobel Limited Analysis

Data as of 2026-06-12 - not real-time

A$3.86

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Dyno Nobel’s share price of AUD 3.86 sits comfortably above its 20‑day (3.74), 50‑day (3.47) and 200‑day (3.29) moving averages, confirming a bullish technical backdrop. Momentum remains strong with an RSI of 68.8 and an upward price trend, although the MACD histogram has turned slightly negative, signalling a potential short‑term pull‑back as the stock approaches its resistance around AUD 3.90. Volume is on an increasing trajectory, reinforcing the current trend, while the 30‑day volatility of nearly 28 % and a low beta of 0.36 suggest modest price swings relative to the market.
Fundamentally, the company delivered a 9.2 % revenue increase to AUD 3.9 bn and maintains a solid gross margin of 56.9 %, yet net profit remains marginally negative, reflected in a trailing profit margin of -1.0 %. The dividend yield of 3.65 % is attractive, but the high payout ratio of 84 % raises questions about long‑term sustainability given the current earnings profile. Free cash flow of AUD 0.83 bn and a cash balance of AUD 0.18 bn provide a cushion against the sizable debt load, while the DCF‑derived fair value of AUD 8.32 implies significant upside, even though analyst consensus targets (mean AUD 3.61) suggest modest downside. Overall, the stock presents a blend of growth momentum and value considerations, tempered by regulatory exposure in the explosives sector and a moderate leverage profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at AUD 3.90
  • MACD histogram turning negative
  • High RSI indicating limited upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained bullish trend above all SMAs
  • Increasing volume and solid revenue growth
  • Attractive dividend yield despite payout concerns

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests substantial upside
  • Low beta and stable cash generation
  • Strategic share buy‑back and dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
Profit Margin-1.04%
P/E Ratio27.6
ROE5.76%
ROA4.95%
Debt/Equity39.65
P/B Ratio1.7
Op. Cash FlowA$347.4M
Free Cash FlowA$831.5M

Technical Analysis

TrendBullish
RSI68.8
SupportA$3.58
ResistanceA$3.90
MA 20A$3.74
MA 50A$3.47
MA 200A$3.29
MACDBearish
VolumeIncreasing
Fear & Greed Index86.59

Valuation

Fair ValueA$8.32
Target PriceA$3.61
Upside/Downside-6.58%
GradeFair
TypeBlend
Dividend Yield3.65%

Risk Assessment

Beta0.37
Volatility27.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.